Jason O'Byrne insider trades

Open-market stock purchases and sales by Jason O'Byrne, CHIEF FINANCIAL OFFICER at Olema Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 20, 2021.

Recent trades

DateStockTradeValue
Sep 1, 2026OLMA Olema Pharmaceuticals, IncBought (not open market)—
Mar 20, 2026VIR Vir Biotechnology, IncBought (not open market)—
Feb 24, 2026VIR Vir Biotechnology, IncSold$15.6K
Feb 23, 2026VIR Vir Biotechnology, IncSold$15.6K
Feb 22, 2026VIR Vir Biotechnology, IncBought (not open market)—
Feb 22, 2026VIR Vir Biotechnology, IncBought (not open market)—
Nov 17, 2025VIR Vir Biotechnology, IncSold$37.8K

Companies traded

  • OLMA Olema Pharmaceuticals, Inc: other filings, last Sep 1, 2026
  • VIR Vir Biotechnology, Inc: 3 sales, last Mar 20, 2026
  • CRBU Caribou Biosciences, Inc: other filings, last Feb 20, 2024

Get free alerts when Jason O'Byrne files a new trade →